BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11685888)

  • 1. Variant proteins on the surface of malaria-infected erythrocytes--developing vaccines.
    Duffy PE; Craig AG; Baruch DI
    Trends Parasitol; 2001 Aug; 17(8):354-6. PubMed ID: 11685888
    [No Abstract]   [Full Text] [Related]  

  • 2. Pregnancy-associated malaria--on the brink?
    Craig AG
    Trends Parasitol; 2004 May; 20(5):201-4. PubMed ID: 15105015
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of vaccines against Plasmodium falciparum malaria: taking lessons from naturally acquired protective immunity.
    Hviid L
    Microbes Infect; 2007 May; 9(6):772-6. PubMed ID: 17398137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics of B cell responses to Plasmodium falciparum erythrocyte membrane protein 1 in Ghanaian women naturally exposed to malaria parasites.
    Ampomah P; Stevenson L; Ofori MF; Barfod L; Hviid L
    J Immunol; 2014 Jun; 192(11):5236-44. PubMed ID: 24760153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic differences and conservation among placental Plasmodium falciparum-infected erythrocytes and acquisition of variant-specific and cross-reactive antibodies.
    Beeson JG; Mann EJ; Byrne TJ; Caragounis A; Elliott SR; Brown GV; Rogerson SJ
    J Infect Dis; 2006 Mar; 193(5):721-30. PubMed ID: 16453269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomedicine. Turncoat antibodies.
    Duffy PE; Fried M
    Science; 2001 Sep; 293(5537):2009-10. PubMed ID: 11557864
    [No Abstract]   [Full Text] [Related]  

  • 7. Pregnancy-associated malaria: parasite binding, natural immunity and vaccine development.
    Gamain B; Smith JD; Viebig NK; Gysin J; Scherf A
    Int J Parasitol; 2007 Mar; 37(3-4):273-83. PubMed ID: 17224156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic analysis of ID1-DBL2X predicts its validity as a vaccine candidate in Colombia and supports at least two independently introduced Plasmodium falciparum populations in the region.
    Rajwani J; Klinger CM; Arango E; Arroyo MI; Sabbagh A; Maestre A; Dacks JB; Gnidehou S; Yanow SK
    Infect Genet Evol; 2017 Nov; 55():175-185. PubMed ID: 28893687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
    Sharling L; Enevold A; Sowa KM; Staalsoe T; Arnot DE
    Malar J; 2004 Sep; 3():31. PubMed ID: 15350207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mass spectrometric analysis of Plasmodium falciparum erythrocyte membrane protein-1 variants expressed by placental malaria parasites.
    Fried M; Wendler JP; Mutabingwa TK; Duffy PE
    Proteomics; 2004 Apr; 4(4):1086-93. PubMed ID: 15048989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global genetic diversity of var2csa in Plasmodium falciparum with implications for malaria in pregnancy and vaccine development.
    Benavente ED; Oresegun DR; de Sessions PF; Walker EM; Roper C; Dombrowski JG; de Souza RM; Marinho CRF; Sutherland CJ; Hibberd ML; Mohareb F; Baker DA; Clark TG; Campino S
    Sci Rep; 2018 Oct; 8(1):15429. PubMed ID: 30337594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Geographical distribution of a variant epitope of Pfs48/45, a Plasmodium falciparum transmission-blocking vaccine candidate.
    Drakeley CJ; Duraisingh MT; PĆ³voa M; Conway DJ; Targett GA; Baker DA
    Mol Biochem Parasitol; 1996 Oct; 81(2):253-7. PubMed ID: 8898341
    [No Abstract]   [Full Text] [Related]  

  • 13. Malaria's deadly grip: cytoadhesion of Plasmodium falciparum-infected erythrocytes.
    Smith JD; Rowe JA; Higgins MK; Lavstsen T
    Cell Microbiol; 2013 Dec; 15(12):1976-83. PubMed ID: 23957661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a vaccine against pregnancy-associated malaria.
    Tuikue Ndam N; Deloron P
    Parasite; 2008 Sep; 15(3):515-21. PubMed ID: 18814733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies and Plasmodium falciparum merozoites.
    Ramasamy R; Ramasamy M; Yasawardena S
    Trends Parasitol; 2001 Apr; 17(4):194-7. PubMed ID: 11282510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoadhesion of Plasmodium falciparum-infected erythrocytes and the infected placenta: a two-way pathway.
    Costa FT; Avril M; Nogueira PA; Gysin J
    Braz J Med Biol Res; 2006 Dec; 39(12):1525-36. PubMed ID: 17160261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines against the blood stages of falciparum malaria.
    Miller LH; Good MF; Kaslow DC
    Adv Exp Med Biol; 1998; 452():193-205. PubMed ID: 9889974
    [No Abstract]   [Full Text] [Related]  

  • 18. Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection.
    Mount AM; Mwapasa V; Elliott SR; Beeson JG; Tadesse E; Lema VM; Molyneux ME; Meshnick SR; Rogerson SJ
    Lancet; 2004 Jun; 363(9424):1860-7. PubMed ID: 15183624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma antibodies from malaria-exposed pregnant women recognize variant surface antigens on Plasmodium falciparum-infected erythrocytes in a parity-dependent manner and block parasite adhesion to chondroitin sulfate A.
    Ricke CH; Staalsoe T; Koram K; Akanmori BD; Riley EM; Theander TG; Hviid L
    J Immunol; 2000 Sep; 165(6):3309-16. PubMed ID: 10975848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malaria vaccines based on the Plasmodium falciparum merozoite surface protein 3--should we avoid amino acid sequence polymorphisms or embrace them?
    Saul A
    J Infect Dis; 2007 Jan; 195(2):171-3. PubMed ID: 17191161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.